Related Experiment Video
Updated: May 23, 2026
08:43
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017
A rapid fluorescent screening method for cellular sensitivity to anti-cancer compound
Wenwei Mao1, Xinlin Chen, Tian Yang
1Lab of Microbial and Biochemical Pharmaceutical, School of Pharmacy, Shanghai Jiaotong University, 800 Dong Chuan Road, Minhang District, Shanghai, 200240, China.
Cytotechnology
|April 6, 2012
Summary
A new method using the fluorescent dye DCFH-DA offers a rapid way to test anticancer drug sensitivity. This method shows reliable results comparable to MTT assays, making it suitable for high-throughput drug screening.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- Traditional cell sensitivity assays for anticancer compounds include MTT and resazurin-based methods.
- These methods are crucial for determining drug efficacy and guiding cancer treatment strategies.
Purpose of the Study:
- To introduce and validate a novel, rapid fluorescent method using 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) for assessing cellular sensitivity to anticancer agents.
- To compare the performance of the DCFH-DA method with the established MTT assay for anticancer drug screening.
Main Methods:
- Utilized DCFH-DA, a fluorescent probe for intracellular hydrogen peroxide (H2O2), to determine cell number and sensitivity.
- Investigated the linearity between cell count and fluorescent intensity using both resuspended and adherent cells.
- Compared IC50 values obtained via DCFH-DA and MTT assays using the anticancer compound Baicalin.
Main Results:
- Demonstrated a strong correlation between cell number and fluorescent intensity measured by the DCFH-DA method.
- Found no significant differences in determining cellular sensitivity to Baicalin between the DCFH-DA and MTT methods.
- Observed a higher coefficient of variation for IC50 values with the DCFH-DA method compared to the MTT method.
Conclusions:
- DCFH-DA is a viable fluorescent dye for assessing anticancer compound sensitivity, offering a rapid alternative to traditional assays.
- The DCFH-DA method's reliability and correlation with existing assays suggest its suitability for high-throughput drug screening and H2O2 level determination.
